ReproCELL Incorporated Logo

ReproCELL Incorporated

Provider of stem cell technology and services for research and regenerative medicine.

4978 | T

Overview

Corporate Details

ISIN(s):
JP3974770004
LEI:
Country:
Japan
Address:
横浜市港北区新横浜3−8−11

Description

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-13 07:35
確認書
Japanese ZIP 8.1 KB
2025-11-13 07:35
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese ZIP 219.0 KB
2025-06-26 02:41
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 23.4 KB
2025-06-26 02:41
確認書
Japanese ZIP 8.1 KB
2025-06-26 02:40
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 1.1 MB
2024-11-13 07:31
確認書
Japanese ZIP 8.1 KB
2024-11-13 07:31
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 221.1 KB
2024-06-26 03:02
臨時報告書
Japanese ZIP 28.0 KB
2024-06-25 07:31
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 22.2 KB
2024-06-25 07:30
確認書
Japanese ZIP 8.2 KB
2024-06-25 07:29
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 1.2 MB
2024-05-23 08:02
臨時報告書
Japanese ZIP 20.0 KB
2024-02-09 07:24
確認書
Japanese ZIP 8.2 KB
2024-02-09 07:23
四半期報告書-第22期第3四半期(2023/10/01-2023/12/31)
Japanese ZIP 227.6 KB
2023-11-10 07:05
四半期報告書-第22期第2四半期(2023/07/01-2023/09/30)
Japanese ZIP 213.2 KB

Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ReproCELL Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Elicera Therapeutics AB Logo
Clinical-stage immuno-oncology company developing cell and gene therapies for cancer.
Sweden
ELIC
Elicio Therapeutics, Inc. Logo
Clinical-stage biotech developing lymph node-targeted immunotherapies for cancer.
United States of America
ELTX
E-Novia Logo
A venture studio and consultancy that transforms Physical AI research into products.
Italy
E9IA
Ensysce Biosciences, Inc. Logo
Clinical-stage pharma firm developing abuse-deterrent drugs for severe pain.
United States of America
ENSC
Enveric Biosciences, Inc. Logo
Develops novel small-molecule therapeutics for neuropsychiatric disorders.
United States of America
ENVB
Eone Diagnomics Genome Center Co., Ltd. Logo
A healthcare company specializing in genetic analysis for personalized medicine.
South Korea
245620
Develops hair loss therapies and provides preclinical CRO services.
South Korea
446440
Equillium, Inc. Logo
Clinical-stage biotech developing therapies for autoimmune & inflammatory disorders.
United States of America
EQ
Eurofins-Cerep Logo
Contract research organization for pre-clinical in vitro drug discovery services.
France
ALECR
Evaxion A/S Logo
A clinical-stage TechBio company developing immunotherapies using an AI platform.
United States of America
EVAX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.